Semaglutide B12 Dosage Chart: What the Research Actually Shows

Semaglutide (Wegovy) contains no B12, the "combination dosage chart" circulating online refers to unlicensed compounded preparations not available or legal through UK pharmacies.
Licensed semaglutide in the UK follows a stepwise dose schedule set by your prescriber; the starting dose is 0.25 mg, titrated roughly every four weeks toward a 2.4 mg maintenance dose.
B12 deficiency is worth discussing with your GP or prescriber if you are on semaglutide, because reduced appetite and food intake can affect nutrient status over time, but supplementation is a separate clinical decision, not a standard add-on.
Every repeat of Wegovy through nume includes a clinical review before dispatch; questions about nutrient monitoring, including B12, can be raised at any stage through our 7-day aftercare team.

Searches for a "semaglutide B12 dosage chart" reflect a widespread assumption: that vitamin B12 is an official part of semaglutide treatment, dosed alongside it on a fixed schedule. It is not. Semaglutide — sold in the UK for weight management as Wegovy — is a GLP-1 receptor agonist licensed on its own, with no B12 component in its formulation or prescribing schedule. The confusion is understandable: some private compounding clinics outside the UK have blended B12 with unlicensed semaglutide preparations, and those protocols circulate widely online. What follows explains what licensed semaglutide actually involves, why B12 monitoring can matter separately, and how to get proper clinical guidance, because a chart downloaded from the internet is not a substitute for a prescriber who knows your full picture.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Where the B12 chart myth comes from, and what licensed semaglutide actually looks like

The compounding clinic connection: why a "semaglutide B12 dosage chart" exists at all

In the United States, some private weight-loss clinics have dispensed compounded semaglutide (a version manufactured outside the licensed supply chain) mixed with vitamin B12, vitamin B6 or other additives. These clinics sometimes publish dosing charts showing how many units to draw from a vial alongside a B12 injection. That content travels freely online, and UK readers searching for a dosage chart often land on it without realising it describes something neither licensed nor available in Great Britain.

In the UK, Wegovy is a pre-filled, pre-set pen. There is no vial, no syringe, no ml-to-mg conversion to perform at home, and no B12 in the pen. The semaglutide dosage schedule is set by your prescriber based on your tolerability and clinical history, then confirmed in the Patient Information Leaflet supplied with the pen. Anyone offering a UK patient a "semaglutide B12 combination" through an online seller almost certainly is not operating through the licensed UK supply chain, a serious safety concern the MHRA has warned about repeatedly.

The MHRA's public guidance on GLP-1 medicines makes clear that medicines sold without a valid prescription from an unverified source carry real risks, including contamination and incorrect concentration. If you have seen a dosing chart online and wondered whether it applies to you, it almost certainly does not.

Does semaglutide affect B12 levels, and should you check yours?

This is the legitimate question buried inside the search. Semaglutide slows gastric emptying and, for many people, substantially reduces appetite and overall food intake. Eating less (particularly less meat, fish, eggs and dairy) can reduce dietary B12 over time. There is also early research suggesting GLP-1 receptor agonists may influence gastric acid secretion, which plays a role in releasing B12 from food. The evidence is not yet definitive enough for NICE or the NHS to recommend routine B12 screening for everyone on Wegovy, but it is a reasonable thing to raise with your prescriber, particularly if you follow a vegetarian or vegan diet or have had gut surgery.

Symptoms of B12 insufficiency (fatigue, tingling in the hands or feet, low mood, difficulty concentrating) can overlap with side effects of semaglutide itself, which makes clinical assessment rather than self-supplementation the sensible approach. A blood test costs very little at a GP practice and gives you an actual number to act on. The Wegovy dose schedule page covers the licensed titration steps in more detail, which may help you frame that conversation with your doctor.

If a deficiency is confirmed, your GP will advise on the appropriate form and dose of B12 replacement, oral tablets or intramuscular injections depending on the cause and severity. That decision sits with your clinical team, not with a generic chart.

What the licensed Wegovy dose schedule does look like

Because many people arrive at this page wanting to understand the actual semaglutide schedule, it is worth being clear. Licensed Wegovy (injection) starts at 0.25 mg once weekly. The prescriber moves the dose up roughly every four weeks: 0.5 mg, then 1.0 mg, then 1.7 mg, reaching the 2.4 mg maintenance dose. In April 2026 the MHRA approved a higher 7.2 mg dose in a dedicated single-dose pen, for adults with a BMI of 30 or above; the titration to that level still begins at 0.25 mg, and you can see how each step maps out in the 10 mg semaglutide dosage chart, which covers the higher end of the dose range in detail. For reference on how ml figures relate to these mg doses in research contexts, the semaglutide ml-to-mg page explains the conversion, though it is worth emphasising that with pre-filled UK pens, you never draw or measure a dose yourself.

Through nume (sorry, through our pharmacy) each pen arrives by DPD the next working day in plain, unbranded packaging, with tracking sent to your phone. The pen comes ready to use; the Patient Information Leaflet inside sets out storage, injection technique and what to do if a dose is missed. Dose changes are made only after a clinical review, not automatically. If you are curious about Wegovy pricing in the private market, that page gives honest context on what the cost covers.

Semaglutide is a prescription-only medicine. A prescriber assesses whether it is clinically suitable for you before any treatment begins, eligibility is not decided by a BMI number alone.

Raising nutrient questions with your prescriber, how it works at nume

A question our prescribers hear regularly: "Can I take B12 alongside Wegovy?" The honest answer is that oral B12 supplements are generally low-risk and widely available, but whether you need one, and at what level, is worth confirming rather than assuming. If you are already taking supplements, tell your prescriber during the consultation, it is part of the medical picture.

For people starting treatment or already on it, the weight-loss treatments page is the right starting point for a free consultation. Our prescribers are GPhC-registered; a real clinician reads your answers the same day, not software. Aftercare is available seven days a week if a question comes up mid-treatment, including questions about nutrition, monitoring or what to do if you are not feeling well on your current dose. You can also browse the FAQs for answers to common questions before you begin.

The NHS's own guidance on semaglutide side effects and how to take it is a reliable first reference. For the clinical evidence behind the licensed dose schedule, NICE's appraisal of semaglutide for weight management (TA875) sets out the framework UK prescribers follow.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions